NYSEArca - Delayed Quote USD

SPDR S&P Biotech ETF (XBI)

83.49 +1.27 (+1.54%)
At close: April 26 at 4:00 PM EDT
83.55 +0.06 (+0.07%)
After hours: April 26 at 7:58 PM EDT

Top 10 Holdings (10.92% of Total Assets)

SymbolCompany% Assets
EXAS
Exact Sciences Corporation 1.16%
VKTX
Viking Therapeutics, Inc. 1.16%
CRNX
Crinetics Pharmaceuticals, Inc. 1.12%
EXEL
Exelixis, Inc. 1.08%
BBIO
BridgeBio Pharma, Inc. 1.08%
CYTK
Cytokinetics, Incorporated 1.08%
DYN
Dyne Therapeutics, Inc. 1.08%
MDGL
Madrigal Pharmaceuticals, Inc. 1.06%
SRPT
Sarepta Therapeutics, Inc. 1.05%
AMGN
Amgen Inc. 1.05%

Sector Weightings

SectorXBI
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.91%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.24
Price/Sales 0.13
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

ETF Overview

Category Health
Fund Family SPDR State Street Global Advisors
Net Assets 7.55B
YTD Daily Total Return -6.50%
Yield 0.02%
Legal Type Exchange Traded Fund

Related Tickers